EPG Online Twitter 
EPG Online Blog 
Disease Knowledge Drug Updates
- Enbrel 25 mg powder and solvent for solution for injection
- Sustiva 50 mg, 100 mg and 200 mg Hard Capsules
- Sandostatin LAR
- Difflam Oral Rinse
- Teoptic 1% - Teoptic 2%
- Erythroped A 500 mg Tablets
- Enalapril 5mg Tablets
- Viskaldix Tablets
- Aricept Tablets
- Difflam Cream
- Alfentanil 500 micrograms/ml solution for injection
- Revlimid
- Benadryl Plus Capsules
- Diclomax Retard
- Voltarol Tablets
- Virgan
- DIXARIT (menopausal disorders)
- Rapiscan (regadenoson)
- Neurontin Capsules and Tablets
- Aprovel Film-Coated Tablets (sanofi-aventis Bristol-Myers Squibb SNC)
- Foradil
- Nystatin-Dome Suspension 100,000 I.U./ml
- Meningitec in pre-filled syringe
- Catapres Tablets 100mcg
- Kemadrin 5 mg Tablets
- SECTRAL 400mg tablets
- Sectral 100mg and 200mg
- Eucardic 25mg Tablets
- ALDOMET Tablets 250 mg
- Parvolex 200 mg/ml Concentrate for Solution for Infusion
- Mifegyne
- Pedea 5 mg/ml solution for injection
- Eucardic 12.5mg Tablets
- Qvar 100 Easi-Breathe
- Qvar 50 Easi-Breathe
- Eucardic 6.25mg Tablets
- Qvar MDI 50 micrograms
- Sonata 5 mg hard capsules
- PRO-EPANUTIN
- Xarelto 20mg film-coated tablets
Contraception
Please note - The EPG Contraception Knowledge Centre is for Doctors and other Healthcare Professionals. Enter the Contraception Knowledge Centre.
The Contraception Knowledge Centre provides help and guidance to assist physicians in selecting the most appropriate contraceptive method for their patient. A woman’s choice of contraception is dictated by a number of factors that influence their decision. These include:
- Age and lifestyle
- Efficacy of method
- Preference for hormonal or non-hormonal method
- Preference for administration regimen
- Acceptability of method
- General health condition
- The need for protection against sexually transmitted diseases
The knowledge centre provides information about the contraceptive options available for men and women. It details hormonal (e.g. Combined Oral Contraception (COC’s), patches, Long-Acting Reversible Contraception (LARC’s) and non-hormonal (Copper intrauterine devices (IUD’s), surgery, barrier methods) options as well as emergency contraception. The information is based on published peer reviews, journals and clinical guidelines (National Institute for Health and Clinical Excellence (NICE) and World Health Organisation (WHO)
Physicians will also find downloadable leaflets for their patient, as well calendar wheels and a list of associations and organizations where they can seek further advice.
EPG Online registered HCP’s who access the resource, will also be able to view a KOL webcast featuring Dr Annie Evans, (a women's health specialist at Bristol Royal Infirmary and Bristol Nuffield Hospitals) , who looks at the clinical implications on LARC’s after the publication of the NICE guidance in 2005.
There is also an interactive case study which looks at the contraceptive choices for a woman who develops focal migraine on the combined oral contraceptive pill.
Enter the Contraception Knowledge Centre
What’s in the Contraception Knowledge Centre?
- NICE Guidelines
- WHO Guidelines
- Contraception Home Page
- Making The Choice
- Calendar Wheels
- Organisations/Associations
- Patient Leaflets
- Emergency Contraception
- Contraception and bone health
- Hormonal Methods - Daily
- Hormonal Methods - LARCs
- Hormonal Methods - Monthly
- Hormonal Methods - Weekly
- Hormonal Methods
- Male Contraception
- Non-Hormonal Methods - Barriers
- Non-Hormonal Methods - IUD
- Non-Hormonal Methods - Surgery
- Non-Hormonal Methods - Traditional Methods
- Non-Hormonal Methods
- Oral contraception is used daily
- E-leave Piece for GP's
- Case Study - Focal Migraine
- KOL - Webcast
- Case Study - LARC
- Case Study - WHO Guidance
- Case Study
